Venture Capital
Andrea Alms Video: Money In Motion 61 - The Vaccine Manufacturing Market Part 2
June 2023 - Venture Capital
TRANSCRIPT
Hello, my name is Andrea Alms and I'm technology investor and financial manager and this is your money in motion. As you may recall, on the previous episode, we introduced the global vaccine contract
manufacturing market as a refresher averaging the averages. The market is 2.2 billion and the average growth rate of 10.5%. Even with different forecast periods, the growth rate and Delta held, what is it, vaccine contract Vaccine manufacturing is a multi-stage process that often requires extensive collaboration, smaller as well as larger firms. Consider outsourcing a cost effective approach to improve product pipeline. However, few large firms consider outsourcing risky due to the strategic control and limited management control. Owing to this, large, pharmaceutical companies may choose to maintain their own manufacturing operations in-house. Still, the contract manufacturing service market is a multibillion dollars and growing at about 10% growth rate. So who are the players? The players come in three categories sponsors, contract manufacturers, equipment and other suppliers. For example, the United States spent heavily and relatively early in 2020 to subsidize and invest in many steps of this supply chain. Thus, be wary. A lot of growth came from government spending and spending dried up. The share price of most have dropped. Still considers, but spreading your bets across the supply chain. As you know, government spending is a roller coaster and remember to stay ahead of the wave. Thank you. This is your money, your money, in motion.